Search

Your search keyword '"Nef HM"' showing total 4 results
Start Over Author "Nef HM" Database OAIster
4 results on '"Nef HM"'

1. Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology

Author

IJsselmuiden, AJJ, Zwaan, EM, Oemrawsingh, Rohit, Bom, MJ, Dankers, F, de Boer, MJ, Camaro, C, van Geuns, Robert Jan, Daemen, Joost, van der Heijden, DJ, Jukema, JW, Kraaijeveld, AO, Meuwissen, M, Scholzel, BE, Pundziute, G, van der Harst, P, van Ramshorst, J, Dirksen, MT, Zivelonghi, C, Agostoni, P, Van der Heyden, JAS, Wykrzykowska, JJ, Scholte, MJ, Nef, HM, Kofflard, MJM, van Royen, N, Alings, M, Kedhi, E, IJsselmuiden, AJJ, Zwaan, EM, Oemrawsingh, Rohit, Bom, MJ, Dankers, F, de Boer, MJ, Camaro, C, van Geuns, Robert Jan, Daemen, Joost, van der Heijden, DJ, Jukema, JW, Kraaijeveld, AO, Meuwissen, M, Scholzel, BE, Pundziute, G, van der Harst, P, van Ramshorst, J, Dirksen, MT, Zivelonghi, C, Agostoni, P, Van der Heyden, JAS, Wykrzykowska, JJ, Scholte, MJ, Nef, HM, Kofflard, MJM, van Royen, N, Alings, M, and Kedhi, E

Published
2018

2. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management

Author

Ghadri, Jr, Wittstein, I, Prasad, A, Sharkey, S, Dote, K, Akashi, Yj, Cammann, Vl, Crea, Filippo, Galiuto, Leonarda, Desmet, W, Yoshida, T, Manfredini, R, Eitel, I, Kosuge, M, Nef, Hm, Deshmukh, A, Lerman, A, Bossone, E, Citro, R, Ueyama, T, Corrado, D, Kurisu, S, Ruschitzka, F, Winchester, D, Lyon, Ar, Omerovic, E, Bax, Jj, Meimoun, P, Tarantini, G, Rihal, C, Y-Hassan, S, Migliore, F, Horowitz, Jd, Shimokawa, H, Lüscher, Tf, Templin, C, Crea F (ORCID:0000-0001-9404-8846), Galiuto L (ORCID:0000-0002-6831-479X), Ghadri, Jr, Wittstein, I, Prasad, A, Sharkey, S, Dote, K, Akashi, Yj, Cammann, Vl, Crea, Filippo, Galiuto, Leonarda, Desmet, W, Yoshida, T, Manfredini, R, Eitel, I, Kosuge, M, Nef, Hm, Deshmukh, A, Lerman, A, Bossone, E, Citro, R, Ueyama, T, Corrado, D, Kurisu, S, Ruschitzka, F, Winchester, D, Lyon, Ar, Omerovic, E, Bax, Jj, Meimoun, P, Tarantini, G, Rihal, C, Y-Hassan, S, Migliore, F, Horowitz, Jd, Shimokawa, H, Lüscher, Tf, Templin, C, Crea F (ORCID:0000-0001-9404-8846), and Galiuto L (ORCID:0000-0002-6831-479X)

Abstract

The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the diagnostic workup, outcome, and management. The recommendations are based on interpretation of the limited clinical trial data currently available and experience of international TTS experts. It summarizes the diagnostic approach, which may facilitate correct and timely diagnosis. Furthermore, the document covers areas where controversies still exist in risk stratification and management of TTS. Based on available data the document provides recommendations on optimal care of such patients for practising physicians.

Published
2018

3. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology

Author

Ghadri, Jr, Wittstein, I, Prasad, A, Sharkey, S, Dote, K, Akashi, Yj, Cammann, Vl, Crea, Filippo, Galiuto, Leonarda, Desmet, W, Yoshida, T, Manfredini, R, Eitel, I, Kosuge, M, Nef, Hm, Deshmukh, A, Lerman, A, Bossone, E, Citro, R, Ueyama, T, Corrado, D, Kurisu, S, Ruschitzka, F, Winchester, D, Lyon, Ar, Omerovic, E, Bax, Jj, Meimoun, P, Tarantini, G, Rihal, C, Y-Hassan, S, Migliore, F, Horowitz, Jd, Shimokawa, H, Lüscher, Tf, Templin, C, Crea F (ORCID:0000-0001-9404-8846), Galiuto L (ORCID:0000-0002-6831-479X), Ghadri, Jr, Wittstein, I, Prasad, A, Sharkey, S, Dote, K, Akashi, Yj, Cammann, Vl, Crea, Filippo, Galiuto, Leonarda, Desmet, W, Yoshida, T, Manfredini, R, Eitel, I, Kosuge, M, Nef, Hm, Deshmukh, A, Lerman, A, Bossone, E, Citro, R, Ueyama, T, Corrado, D, Kurisu, S, Ruschitzka, F, Winchester, D, Lyon, Ar, Omerovic, E, Bax, Jj, Meimoun, P, Tarantini, G, Rihal, C, Y-Hassan, S, Migliore, F, Horowitz, Jd, Shimokawa, H, Lüscher, Tf, Templin, C, Crea F (ORCID:0000-0001-9404-8846), and Galiuto L (ORCID:0000-0002-6831-479X)

Abstract

Takotsubo syndrome (TTS) is a poorly recognized heart disease that was initially regarded as a benign condition. Recently, it has been shown that TTS may be associated with severe clinical complications including death and that its prevalence is probably underestimated. Since current guidelines on TTS are lacking, it appears timely and important to provide an expert consensus statement on TTS. The clinical expert consensus document part I summarizes the current state of knowledge on clinical presentation and characteristics of TTS and agrees on controversies surrounding TTS such as nomenclature, different TTS types, role of coronary artery disease, and etiology. This consensus also proposes new diagnostic criteria based on current knowledge to improve diagnostic accuracy.

Published
2018

4. Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics

Author

Bauer, T, Mollmann, H, Weidinger, F, Zeymer, U, Seabra-Gomes, R, Eberli, F, Serruys, PWJC (Patrick), Vahanian, A, Silber, S, Wijns, W (William), Hochadel, M, Nef, HM, Hamm, CW, Marco, J, Gitt, AK, Bauer, T, Mollmann, H, Weidinger, F, Zeymer, U, Seabra-Gomes, R, Eberli, F, Serruys, PWJC (Patrick), Vahanian, A, Silber, S, Wijns, W (William), Hochadel, M, Nef, HM, Hamm, CW, Marco, J, and Gitt, AK

Abstract

The most recent ESC guidelines for percutaneous coronary intervention (PCI) recommend the use of glycoprotein IIb/IIIa inhibitors (GPI) in high risk patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), particularly in diabetics. Little is known about the adherence to these guidelines within Europe. Between May 2005 and April 2008 a total of 47,407 consecutive patients undergoing PCI were prospectively enrolled into the PCI-Registry of the Euro Heart Survey Programme. In the present analysis we examined the use of GPI in 2,922 diabetics who underwent PCI for NSTE-ACS. In this high risk population only 22.2% received a GPI; 8.9% upstream and 13.4% during PCI. The strategy of the individual institution had a major impact on the usage of GPI. In the multiple regression analysis clinical instability and complex lesion characteristics were strong independent determinants for the use of GPI, whereas renal insufficiency was negatively associated with its use. After adjustment for confounding variables no significant differences in hospital mortality could be observed between the cohorts, but a significantly higher rate of non-fatal postprocedural myocardial infarction was observed among patients receiving GPI upstream. Despite the recommendation for its use in the current ESC guidelines, only a minority of the diabetics in Europe undergoing PCI for NSTE-ACS received a GPI. The use of GPI was mainly triggered by high-risk interventional scenarios.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results